Following the successful conclusion of another JP Morgan Conference in 2023, Nick sat down with Dr Juana Candia to hear about her take on this year's conference and what we should take from it.

Juana brings more than 20 years of leadership experience in Biotech, Precision Medicine, and Cell & Gene Therapy. She is the co-founder of one of the first Biotech startups in South America, pursued scientific discoveries and built businesses in seven countries and four continents. Accelerated innovation pipelines, authored 20+ patents families, designed, and delivered growth strategies resulting in business turnarounds and double-digit growths while working for Roche, DSM, Novartis, GSK, and Scailyte (Start-up). Currently serving on Boards of Directors and Advisers to emerging companies with transformative technologies and disruptive business models.